Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and subgroup analyses of the intra-patient comparison of the HAVEN 3 trial

Adriana Reyes,Cedric Revil,Markus Niggli,Sammy Chebon,Simone Schlagmüller,J.-P. Flacke,Max Zortel,Ido Paz-Priel,Elina Asikanius,Roger Hampton,Anadi Mahajan,Elvira Schmidt,Susan C. Edwards

Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and subgroup analyses of the intra-patient comparison of the HAVEN 3 trial

2019

Adriana Reyes
Cedric Revil
Markus Niggli
Sammy Chebon
Simone Schlagmüller
J.-P. Flacke
Max Zortel
Ido Paz-Priel
Elina Asikanius
Roger Hampton
Anadi Mahajan
Elvira Schmidt
Susan C. Edwards

AbstractObjectives: To compare the efficacy of emicizumab prophylaxis with that of factor VIII (FVIII) prophylaxis in patients with hemophilia A without inhibitors using two approaches: network met...

Keywords:

Anesthesia
Meta-analysis
Internal medicine
Emicizumab
Diabetes mellitus
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations